DenovAI Biotech

DenovAI Biotech builds a generative AI and physics platform for the de novo design of therapeutic proteins, such as antibodies and miniproteins. They target the biologics discovery market, aiming to reduce drug discovery timelines from years to weeks. The company generates revenue through services and consulting and revenue sharing.